Application of CD4+CD70+T cell subset in preparing reagent for auxiliary diagnosis of very severe aplastic anemia
A technology of aplastic and cell subsets, applied in the field of biomedicine, can solve the problems such as immune-related indicators of VSAA patients that have not been reported, and achieve the effect of broad application prospects.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0049] (1) Blood was collected under the premise of signing the informed consent form with the patient, and all samples were taken from the fasting intravenous EDTA anticoagulation in the morning. A total of 23 peripheral blood samples were collected for AA, including 11 cases of VSAA and 12 cases of SAA. At the same time, 31 samples of healthy people were collected, and this part of the research protocol has been approved by the ethics committee of the unit. At the same time, the clinical data of AA patients were collected (as shown in Table 1).
[0050] Table 1
[0051]
[0052]
[0053] (2) The peripheral blood collected from healthy people and AA patients was lysed with erythrocyte lysate. Proportion 2mL red blood cell lysate per 200μL of peripheral blood, lyse at room temperature for 10min, gently blow and mix once with a pipette during lysis, then centrifuge at 200g for 5min, discard the supernatant, add 1×PBS to 2mL, at 300g Wash by centrifugation, discard the ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com